Revolution Medicines, Inc. Common Stock (RVMD)
Revolution Medicines, Inc. Common Stock
XNAS:RVMD
116
$117.50 - 23.00
$115.00 - 2,000.00
$109.77
$121.62
$120.13
$107.39
121.62
29.17
20790404
6140342.2
165323977.56
Chart
TendieTensor AI Analysis
Company
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
Fundamentals
809
-22.900000
14.094300
100
BBG00829F4P8
BBG00829F4Q7
186.93M
193.32M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own RVMD. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.